FDA-approved for chronic weight management in adults with obesity or overweight who have at least one weight-related condition
Available from: (cited 2025 Jun 11) 105.Hashimoto Takigami N, Kuniyoshi S, Miki Y, Tamaki K, Kamada Y, Uehara K, et al
Comparisons to Other GLP-1 Analogs Compared to other GLP-1 analogs, Semaglutide offers several advantages
HbA1c and fasting glucose: Decrease due to improved blood sugar control Lipid levels: Cholesterol and triglycerides may improve Kidney and liver markers: Monitored during treatment (changes may occur due to dehydration, not direct drug toxicity) Semaglutide is highly unlikely to cause false positives on standard drug tests
It's not an illegal substance, but if you're giving it to someone with the specific use that they're going to be using it, that's, that's actually illegal
The medication comprises the active ingredient Semaglutide, a glucagon-like peptide receptor (GPL-1) drug that helps promote insulin production